Literature DB >> 8378102

The formalin test: a validation of the weighted-scores method of behavioural pain rating.

Terence J Coderre1, Marian E Fundytus, John E McKenna, Suntanu Dalal, Ronald Melzack.   

Abstract

The formalin test was developed using an ordinal scale of weighted scores to rate the intensity of pain-related behaviours in animals. However, no studies have been carried out to establish the ordinal relationship of the behavioural categories used to generate the weighted pain intensity scores. The purpose of the present study was to evaluate the validity of the weighted-scores technique by assessing the ordinality of the behavioural categories associated with the specific category weights. The amount of time spent in each of 4 behavioural categories was measured as a function of the concentration of the formalin solution injected into the hindpaw of rats, and as a function of the dose of systemic morphine given to rats injected with a concentrated (5.0%) solution of formalin. The ordinal nature of the category weights was supported when the data were subjected to a polychotomous logistic regression for fitting an ordinal model.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8378102     DOI: 10.1016/0304-3959(93)90098-A

Source DB:  PubMed          Journal:  Pain        ISSN: 0304-3959            Impact factor:   6.961


  42 in total

1.  D-Amino acid oxidase-mediated increase in spinal hydrogen peroxide is mainly responsible for formalin-induced tonic pain.

Authors:  Jin-Miao Lu; Nian Gong; Yan-Chao Wang; Yong-Xiang Wang
Journal:  Br J Pharmacol       Date:  2012-03       Impact factor: 8.739

2.  Altered morphine-induced analgesia in neurotensin type 1 receptor null mice.

Authors:  G Roussy; H Beaudry; M Lafrance; K Belleville; N Beaudet; K Wada; L Gendron; P Sarret
Journal:  Neuroscience       Date:  2010-08-18       Impact factor: 3.590

3.  A lateralized deficit in morphine antinociception after unilateral inactivation of the central amygdala.

Authors:  B H Manning
Journal:  J Neurosci       Date:  1998-11-15       Impact factor: 6.167

4.  Effects of GABAA receptors in nucleus cuneiformis on the cannabinoid antinociception using the formalin test.

Authors:  Junjie Chen; Parisa Hasanein; Alireza Komaki; Siamak Yari
Journal:  Psychopharmacology (Berl)       Date:  2021-03-13       Impact factor: 4.530

5.  Preclinical Comparison of Mechanistically Different Antiseizure, Antinociceptive, and/or Antidepressant Drugs in a Battery of Rodent Models of Nociceptive and Neuropathic Pain.

Authors:  Misty D Smith; Jose H Woodhead; Laura J Handy; Timothy H Pruess; Fabiola Vanegas; Erin Grussendorf; Joel Grussendorf; Karen White; Karolina K Bulaj; Reisa K Krumin; Megan Hunt; Karen S Wilcox
Journal:  Neurochem Res       Date:  2017-05-15       Impact factor: 3.996

6.  An opioidergic cortical antinociception triggering site in the agranular insular cortex of the rat that contributes to morphine antinociception.

Authors:  A R Burkey; E Carstens; J J Wenniger; J Tang; L Jasmin
Journal:  J Neurosci       Date:  1996-10-15       Impact factor: 6.167

7.  Metabolic brain activity suggestive of persistent pain in a rat model of neuropathic pain.

Authors:  Scott J Thompson; Magali Millecamps; Antonio Aliaga; David A Seminowicz; Lucie A Low; Barry J Bedell; Laura S Stone; Petra Schweinhardt; M Catherine Bushnell
Journal:  Neuroimage       Date:  2014-01-21       Impact factor: 6.556

8.  siRNA-mediated knockdown of the NR1 subunit gene of the NMDA receptor attenuates formalin-induced pain behaviors in adult rats.

Authors:  Sandra M Garraway; Qinghao Xu; Charles E Inturrisi
Journal:  J Pain       Date:  2009-01-29       Impact factor: 5.820

9.  Role of central muscarinic cholinergic receptors in the formalin-induced pain in rats.

Authors:  Ali Mojtahedin; Esmaeal Tamaddonfard; Ali Zanbouri
Journal:  Indian J Pharmacol       Date:  2009-06       Impact factor: 1.200

10.  Evidence for a role of NTS2 receptors in the modulation of tonic pain sensitivity.

Authors:  Geneviève Roussy; Marc-André Dansereau; Stéphanie Baudisson; Faouzi Ezzoubaa; Karine Belleville; Nicolas Beaudet; Jean Martinez; Elliott Richelson; Philippe Sarret
Journal:  Mol Pain       Date:  2009-07-06       Impact factor: 3.395

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.